Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x100px

Person › Details

Kai Pinkernell (Medigene AG (FSE: MDG1, Prime Standard))

Pinkernell, Kai (Medigene 201602– CMO before Miltenyi Biotec + Cytori Therapeutics)

	Organisation	Medigene AG (FSE: MDG1, Prime Standard)
	Group	Medigene (Group)
	Product	clinical research
	Product 2	cancer immunotherapy (immuno-oncology, I-O)

Record changed: 2021-02-01

Picture Berlin Partner Events RegMed Forum 2025 HealthCapital 650x200px

More documents for Kai Pinkernell

[1] Medigene AG. (1/28/21). "Press Release: Focus on Solid Tumors – Discontinuation of MDG1021 Development Program". Planegg-Martinsried....
[2] Medigene AG. (10/19/20). "Press Release: Medigene and Cytovant Enter into Service Agreement for DC Vaccine Manufacturing Process Development". Planegg-Martinsried....
[3] Medigene AG. (1/17/19). "Press Release: Medigene Participates at Four Upcoming Conferences". Martinsried....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)